Structural and Functional Integration of the PLCγ Interaction Domains Critical for Regulatory Mechanisms and Signaling Deregulation
Open accessAbstract
Multidomain proteins incorporating interaction domains are central to regulation of cellular processes. The elucidation of structural organization and mechanistic insights into many of these proteins, however, remain challenging due to their inherent flexibility. Here, we describe the organization and function of four interaction domains in PLCγ1 using a combination of structural biology and biochemical approaches. Intramolecular interactions within the regulatory region center on the cSH2 domain, the only domain that also interacts with the PLC-core. In the context of fibroblast growth-factor receptor signaling, the coordinated involvement of nSH2 and cSH2 domains mediates efficient phosphorylation of PLCγ1 resulting in the interruption of an autoinhibitory interface by direct competition and, independently, dissociation of PLCγ1 from the receptor. Further structural insights into the autoinhibitory surfaces provide a framework to interpret gain-of-function mutations in PLCγ isoforms linked to immune disorders and illustrate a distinct mechanism for regulation of PLC activity by common interaction domains.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The N-terminal SH2 (nSH2) domain is positioned at a distance from the core catalytic domains, and is essentially the principal interaction domain for binding to the phosphotyrosine residues in partner proteins.
“The N-terminal SH2 (nSH2) domain is positioned at a distance from the core catalytic domains, and is essentially the principal interaction domain for binding to the phosphotyrosine residues in partner proteins [87].”
From TREM2/PLCγ2 signalling in immune cells: function, structural insight, and potential therapeutic modulation (2021) · cites this paper as [87]
The predicted structures of the wild-type and mutant SH2c domains of PLCγ1 and PLCγ2 and the localizations of residues 687 (γ1) and 665 (γ2) are virtually identical to each other.
“The predicted structures of the wild-type and mutant SH2c domains of PLC␥ 1 and PLC␥ 2 and the localizations of the residues in positions 687 (␥ 1 ) and 665 (␥ 2 ) are virtually identical to each other.”
From The Phospholipase Cγ2 Mutants R665W and L845F Identified in Ibrutinib-resistant Chronic Lymphocytic Leukemia Patients Are Hypersensitive to the Rho GTPase Rac2 Protein (2016) · cites this paper as [67]
The Results sections describe crystal structures of PLCγ1 SH2 domains and experiments with PLCγ1 mutants, but do not compare predicted wild-type and mutant cSH2 structures across PLCγ1 and PLCγ2. Searches for residues 687 and 665 found no passage establishing their corresponding locations or the claimed structural similarity. No page numbers are available in our copy. (LLM, conf=0.75)
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Svergun, D. I. (1999) · Biophysical Journal · doi:10.1016/s0006-3495(99)77443-6 · Cited by 2,229 · see citing works
Self-citation<i>DAMMIF</i> , a program for rapid <i>ab-initio</i> shape determination in small-angle scattering
Franke, D., & Svergun, D. I. (2009) · Journal of Applied Crystallography · doi:10.1107/s0021889809000338 · Cited by 2,021 · see citing works
Self-citationUniqueness of ab initio shape determination in small-angle scattering
Волков, В. В., & Svergun, D. I. (2003) · Journal of Applied Crystallography · doi:10.1107/s0021889803000268 · Cited by 1,911 · see citing works
Self-citationStructural Characterization of Flexible Proteins Using Small-Angle X-ray Scattering
Bernadó, P., Mylonas, E., Petoukhov, M. V., Blackledge, M. J., & Svergun, D. I. (2007) · Journal of the American Chemical Society · doi:10.1021/ja069124n · Cited by 1,172 · see citing works
Self-citationCrystal Structure of the Tyrosine Phosphatase SHP-2
Hof, P., Pluskey, S., Dhe‐Paganon, S., Eck, M. J., & Shoelson, S. E. (1998) · Cell · doi:10.1016/s0092-8674(00)80938-1 · Cited by 996 · see citing works
Cell Signaling in Space and Time: Where Proteins Come Together and When They’re Apart
Scott, J. D., & Pawson, T. J. (2009) · Science · doi:10.1126/science.1175668 · Cited by 648 · see citing works
Multiple roles of phosphoinositide-specific phospholipase C isozymes
Suh, P.-G., Park, J.-I., Manzoli, L., Cocco, L., Peak, J. C., Katan, M., Fukami, K., Kataoka, T., Yun, S.-U., & Ryu, S.-H. (2008) · BMB Reports · doi:10.5483/bmbrep.2008.41.6.415 · Cited by 501 · see citing works
Self-citationCold Urticaria, Immunodeficiency, and Autoimmunity Related to <i>PLCG2</i> Deletions
Ombrello, M. J., Remmers, E. F., Sun, G., Freeman, A. F., Datta, S., Torabi-Parizi, P., Subramanian, N., Bunney, T. D., Baxendale, R. W., Martins, M. S., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1102140 · Cited by 425 · see citing works
Self-citationPhosphoinositide signalling in cancer: beyond PI3K and PTEN
Bunney, T. D., & Katan, M. (2010) · Nature Reviews Cancer · doi:10.1038/nrc2842 · Cited by 400 · see citing works
Self-citationZhou, Q., Lee, G.-S., Brady, J., Datta, S., Katan, M., Sheikh, A., Martins, M. S., Bunney, T. D., Santich, B. H., Moir, S., et al. (2012) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2012.08.006 · Cited by 374 · see citing works
Self-citationStructural analysis of intrinsically disordered proteins by small-angle X-ray scattering
Bernadó, P., & Svergun, D. I. (2011) · Molecular BioSystems · doi:10.1039/c1mb05275f · Cited by 347 · see citing works
Self-citationLiu, B. A., Jablonowski, K. D., Raina, M., Arcé, M., Pawson, T. J., & Nash, P. (2006) · Molecular Cell · doi:10.1016/j.molcel.2006.06.001 · Cited by 294 · see citing works
Structure of Lipid Kinase p110β/p85β Elucidates an Unusual SH2-Domain-Mediated Inhibitory Mechanism
Zhang, X., Vadas, O., Perišić, O., Anderson, K. E., Clark, J. P., Hawkins, P. T., Stephens, L., & Williams, R. L. (2011) · Molecular Cell · doi:10.1016/j.molcel.2011.01.026 · Cited by 212 · see citing works
Filippakopoulos, P., Kofler, M., Hantschel, O. D., Gish, G. D., Grebien, F., Salah, E., Neudecker, P., Kay, L. E., Turk, B. E., Superti‐Furga, G., et al. (2008) · Cell · doi:10.1016/j.cell.2008.07.047 · Cited by 201 · see citing works
PLC regulation: emerging pictures for molecular mechanisms
Bunney, T. D., & Katan, M. (2011) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2010.08.003 · Cited by 182 · see citing works
Self-citationYu, P., Constien, R., Dear, N., Katan, M., Hanke, P., Bunney, T. D., Kunder, S., Quintanilla-Martinez, L., Huffstadt, U., Schröder, A., et al. (2005) · Immunity · doi:10.1016/j.immuni.2005.01.018 · Cited by 177 · see citing works
Self-citationGeneral and Versatile Autoinhibition of PLC Isozymes
Hicks, S. N., Jezyk, M. R., Gershburg, S., Seifert, J. P., Harden, T. K., & Sondek, J. (2008) · Molecular Cell · doi:10.1016/j.molcel.2008.06.018 · Cited by 163 · see citing works
Bae, J. H., Lew, E. D., Yuzawa, S., Tomé, F., Lax, I., & Schlessinger, J. (2009) · Cell · doi:10.1016/j.cell.2009.05.028 · Cited by 158 · see citing works
Structural and Mechanistic Insights into Ras Association Domains of Phospholipase C Epsilon
Bunney, T. D., Harris, R., Gandarillas, N. L., Josephs, M. B., Roe, S. M., Sorli, S., Paterson, H. F., Rodrigues‐Lima, F., Esposito, D., Ponting, C. P., et al. (2006) · Molecular Cell · doi:10.1016/j.molcel.2006.01.008 · Cited by 134 · see citing works
Self-citationSH2 domains: modulators of nonreceptor tyrosine kinase activity
Filippakopoulos, P., Müller, S., & Knapp, S. (2009) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2009.10.001 · Cited by 122 · see citing works
Mechanism of Phosphorylation-induced Activation of Phospholipase C-γ Isozymes
Gresset, A., Hicks, S. N., Harden, T. K., & Sondek, J. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.166512 · Cited by 110 · see citing works
Bunney, T. D., Opaleye, O., Roe, S. M., Vatter, P., Baxendale, R. W., Walliser, C., Everett, K. L., Josephs, M. B., Christow, C., Rodrigues-Lima, F., et al. (2009) · Molecular Cell · doi:10.1016/j.molcel.2009.02.023 · Cited by 72 · see citing works
Self-citationCharacterization of Phospholipase Cγ Enzymes with Gain-of-Function Mutations
Everett, K. L., Bunney, T. D., Yoon, Y., Rodrigues-Lima, F., Harris, R., Driscoll, P. C., Abe, K., Fuchs, H., Hrabé de Angelis, M., Yu, P., et al. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.019265 · Cited by 63 · see citing works
Self-citationAbe, K., Fuchs, H., Boersma, A., Hans, W., Yu, P., Kalaydjiev, S., Klaften, M., Adler, T., Calzada‐Wack, J., Mossbrugger, I., et al. (2011) · Arthritis & Rheumatism · doi:10.1002/art.30280 · Cited by 46 · see citing works
Self-citationCross, M. J., Hodgkin, M. N., Roberts, S., Landgren, E., Wakelam, M. J. O., & Claesson, L. (2000) · Journal of Cell Science · doi:10.1242/jcs.113.4.643 · Cited by 44 · see citing works
EGF-Dependent Association of Phospholipase C-γ1 with c-Cbl
Tvorogov, D., & Carpenter, G. F. (2002) · Experimental Cell Research · doi:10.1006/excr.2002.5545 · Cited by 38 · see citing works
Intramolecular Regulation of Phospholipase C-γ1 by Its C-Terminal Src Homology 2 Domain
DeBell, K. E., Graham, L. J., Reischl, I. G., Serrano, C. J., Bonvini, E., & Rellahan, B. L. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.01400-06 · Cited by 36 · see citing works
Membrane Environment Exerts an Important Influence on Rac-Mediated Activation of Phospholipase Cγ2
Everett, K. L., Buehler, A., Bunney, T. D., Margineanu, A., Baxendale, R. W., Vatter, P., Retlich, M., Walliser, C., Manning, H. B., Neil, M. A. A., et al. (2011) · Molecular and Cellular Biology · doi:10.1128/mcb.01408-10 · Cited by 25 · see citing works
Self-citation
Flagged first, then by citations
Cited by
Sorted by citations
Recurrent PTPRB and PLCG1 mutations in angiosarcoma
Behjati, S., Tarpey, P. S., Sheldon, H., Martincorena, I., Loo, P. V., Gundem, G., Wedge, D. C., Ramakrishna, M., Cooke, S. L., Pillay, N., et al. (2014) · Nature Genetics · doi:10.1038/ng.2921 · Cited by 307 · see citing works
Self-citationFibroblast growth factor signalling in osteoarthritis and cartilage repair
Xie, Y., Zinkle, A., Chen, L., & Mohammadi, M. (2020) · Nature Reviews Rheumatology · doi:10.1038/s41584-020-0469-2 · Cited by 186 · see citing works
Dysfunction of phospholipase Cγ in immune disorders and cancer
Koss, H., Bunney, T. D., Behjati, S., & Katan, M. (2014) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2014.09.004 · Cited by 115 · see citing works
Self-citationBill, C., & Vines, C. (2019) · Advances in Experimental Medicine and Biology · doi:10.1007/978-3-030-12457-1_9 · Cited by 107 · see citing works
Receptor tyrosine kinases regulate signal transduction through a liquid-liquid phase separated state
Lin, C., Suen, K. M., Jeffrey, P.-A., Wieteska, Ł., Lidster, J. A., Bao, P., Curd, A., Stainthorp, A. K., Seiler, C., Koss, H., et al. (2022) · Molecular Cell · doi:10.1016/j.molcel.2022.02.005 · Cited by 101 · see citing works
Fibroblast growth factor receptor fusions in cancer: opportunities and challenges
Chen, L., Zhang, Y., Yin, L., Cai, B., Huang, P. C., Li, X., & Liang, G. (2021) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-021-02156-6 · Cited by 93 · see citing works
Phospholipase C families: Common themes and versatility in physiology and pathology
Katan, M., & Cockcroft, S. (2020) · Progress in Lipid Research · doi:10.1016/j.plipres.2020.101065 · Cited by 89 · see citing works
Self-citationHajicek, N., Keith, N. C., Siraliev-Perez, E., Temple, B. R., Huang, W., Zhang, Q., Harden, T. K., & Sondek, J. (2019) · eLife · doi:10.7554/elife.51700 · Cited by 89 · see citing works
PLAID: a Syndrome of Complex Patterns of Disease and Unique Phenotypes
Milner, J. D. (2015) · Journal of Clinical Immunology · doi:10.1007/s10875-015-0177-x · Cited by 85 · see citing works
Jones, D., Woyach, J. A., Zhao, W., Caruthers, S., Tu, H., Coleman, J., Byrd, J. C., Johnson, A. J., & Lozanski, G. (2017) · Leukemia · doi:10.1038/leu.2017.110 · Cited by 71 · see citing works
Garré, J. M., Yang, G., Bukauskas, F. F., & Bennett, M. V. L. (2016) · Journal of Neuroscience · doi:10.1523/jneurosci.4195-15.2016 · Cited by 68 · see citing works
Magno, L., Bunney, T. D., Mead, E., Svensson, F., & Bictash, M. N. (2021) · Molecular Neurodegeneration · doi:10.1186/s13024-021-00436-5 · Cited by 64 · see citing works
Self-citationTwo FGF Receptor Kinase Molecules Act in Concert to Recruit and Transphosphorylate Phospholipase Cγ
Huang, Z., Marsiglia, W. M., Roy, U. B., Rahimi, N., Ilghari, D., Wang, H., Chen, H., Gai, W., Blais, S. P., Neubert, T. A., et al. (2015) · Molecular Cell · doi:10.1016/j.molcel.2015.11.010 · Cited by 59 · see citing works
Quinoline‐based promising anticancer and antibacterial agents, and some metabolic enzyme inhibitors
Ökten, S., Aydın, A. O., Koçyiğit, Ü. M., Çakmak, O., Erkan, S., Andac, C. A., Taslımı, P., & Gülçın, İ. (2020) · Archiv der Pharmazie · doi:10.1002/ardp.202000086 · Cited by 59 · see citing works
Hajicek, N., & Sondek, J. (2019) · Worldwide Protein Data Bank · doi:10.2210/pdb6pbc/pdb · Cited by 58 · see citing works
Molecular subtypes in canine hemangiosarcoma reveal similarities with human angiosarcoma
Wang, G., Wu, M., Durham, A. C., Radaelli, E., Mason, N. J., Xu, X., & Roth, D. B. (2020) · PLoS ONE · doi:10.1371/journal.pone.0229728 · Cited by 56 · see citing works
Bunney, T. D., Cole, A. R., Broncel, M., Esposito, D., Tate, E. W., & Katan, M. (2014) · Structure · doi:10.1016/j.str.2014.10.007 · Cited by 54 · see citing works
Self-citationDermatologic and Dermatopathologic Features of Monogenic Autoinflammatory Diseases
Figueras‐Nart, I., Mascaró, J. M., Solanich, X., & Hernández‐Rodríguez, J. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02448 · Cited by 53 · see citing works
Walliser, C., Hermkes, E., Schade, A., Wiese, S., Deinzer, J., Zapatka, M., Désiré, L., Mertens, D., Stilgenbauer, S., & Gierschik, P. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.746842 · Cited by 51 · see citing works
Competition between Grb2 and Plcγ1 for FGFR2 regulates basal phospholipase activity and invasion
Timsah, Z., Ahmed, Z., Lin, C., Melo, F. A., Stagg, L., Leonard, P. G., Jeyabal, P., Berrout, J., O’Neil, R. G., Bogdanov, M. V., et al. (2014) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.2752 · Cited by 51 · see citing works
Angioimmunoblastic T cell lymphoma: novel molecular insights by mutation profiling
Wang, M., Zhang, S., Chuang, S., Ashton‐Key, M., Ochoa, E., Bolli, N., Vassiliou, G. S., Gao, Z., & Du, M. (2017) · Oncotarget · doi:10.18632/oncotarget.14846 · Cited by 48 · see citing works
Emerging roles of PLCγ1 in endothelial biology
Chen, D.-Y., & Simons, M. (2021) · Science Signaling · doi:10.1126/scisignal.abc6612 · Cited by 34 · see citing works
Liu, Y., Bunney, T. D., Khosa, S., Macé, K., Beckenbauer, K., Askwith, T., Maslen, S., Stubbs, C., de Oliveira, T. M., Sader, K., et al. (2020) · EBioMedicine · doi:10.1016/j.ebiom.2019.102607 · Cited by 42 · see citing works
Self-citationEndothelial cell malignancies: new insights from the laboratory and clinic
Wagner, M. J., Ravi, V., Menter, D. G., & Sood, A. K. (2017) · npj Precision Oncology · doi:10.1038/s41698-017-0013-2 · Cited by 38 · see citing works
Multidomain Control Over TEC Kinase Activation State Tunes the T Cell Response
Andreotti, A. H., Joseph, R. E., Conley, J. M., Iwasa, J., & Berg, L. J. (2018) · Annual Review of Immunology · doi:10.1146/annurev-immunol-042617-053344 · Cited by 38 · see citing works
Weak protein–ligand interactions studied by small‐angle X ‐ray scattering
Tuukkanen, A. T., & Svergun, D. I. (2014) · FEBS Journal · doi:10.1111/febs.12772 · Cited by 36 · see citing works
Self-citationJattani, R. P., Tritapoe, J. M., & Pomerantz, J. L. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.683714 · Cited by 36 · see citing works
Wang, J., Sohn, H., Sun, G., Milner, J. D., & Pierce, S. K. (2014) · Science Signaling · doi:10.1126/scisignal.2005392 · Cited by 36 · see citing works
Comparative analysis of interactions of RASSF1-10
Chan, J. J., Flatters, D., Rodrigues‐Lima, F., Yan, J., Thalassinos, K., & Katan, M. (2013) · Advances in Biological Regulation · doi:10.1016/j.jbior.2012.12.001 · Cited by 35 · see citing works
Self-citationPatel, V. M., Flanagan, C. E., Martins, M., Jones, C. L., Butler, R. M., Woollard, W. J., Bakr, F. S., Yoxall, A., Begum, N., Katan, M., et al. (2019) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2019.07.693 · Cited by 31 · see citing works
Self-citationSpecificity and regulation of phosphotyrosine signaling through SH2 domains
Marasco, M., & Carlomagno, T. (2020) · Journal of Structural Biology X · doi:10.1016/j.yjsbx.2020.100026 · Cited by 31 · see citing works
PLCγ1 suppression promotes the adaptation of KRAS-mutant lung adenocarcinomas to hypoxia
Saliakoura, M., Sebastiano, M. R., Pozzato, C., Heidel, F. H., Schnoeder, T. M., Prince, S. S., Bubendorf, L., Pinton, P., Schmid, R. A., Baumgartner, J., et al. (2020) · Nature Cell Biology · doi:10.1038/s41556-020-00592-8 · Cited by 31 · see citing works
Gramolelli, S., Weidner-Glunde, M., Abere, B., Viejo‐Borbolla, A., Bala, K., Rückert, J., Kremmer, E., & Schulz, T. F. (2015) · PLoS Pathogens · doi:10.1371/journal.ppat.1005105 · Cited by 30 · see citing works
Fine Specificity and Molecular Competition in SLAM Family Receptor Signalling
Wilson, T. J., Garner, L. I., Metcalfe, C. L., King, E., Margraf, S., & Brown, M. H. (2014) · PLoS ONE · doi:10.1371/journal.pone.0092184 · Cited by 28 · see citing works
Cool-temperature-mediated activation of phospholipase C-γ 2 in the human hereditary disease PLAID
Schade, A., Walliser, C., Wist, M., Haas, J., Vatter, P., Kraus, J. M., Filingeri, D., Havenith, G., Kestler, H. A., Milner, J. D., et al. (2016) · Cellular Signalling · doi:10.1016/j.cellsig.2016.05.010 · Cited by 28 · see citing works
Jasemi, N. S. K., Herrmann, C., Estirado, E. M., Gremer, L., Willbold, D., Brunsveld, L., Dvorský, R., & Ahmadian, M. R. (2021) · Biochemical Journal · doi:10.1042/bcj20210105 · Cited by 26 · see citing works
Biological activity and molecular docking studies of some new quinolines as potent anticancer agents
Köprülü, T. K., Ökten, S., Atalay, V. E., Teki̇n, Ş., & Çakmak, O. (2021) · Medical Oncology · doi:10.1007/s12032-021-01530-w · Cited by 25 · see citing works
Cruz-Duarte, R., de Almeida, C. R., Negrão, M., Fernandes, A., Borralho, P., Sobral, D., Gallego-Paez, L. M., Machado, D., Gramaça, J., Vílchez, J., et al. (2022) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-21-1992 · Cited by 22 · see citing works
Self-citationScaffold Protein SLP-76 Primes PLCγ1 for Activation by ITK-Mediated Phosphorylation
Devkota, S., Joseph, R. E., Min, L., Fulton, D. B., & Andreotti, A. H. (2015) · Journal of Molecular Biology · doi:10.1016/j.jmb.2015.04.012 · Cited by 22 · see citing works
Le Huray, K. I. P., Bunney, T. D., Pinotsis, N., Kalli, A. C., & Katan, M. (2022) · Science Advances · doi:10.1126/sciadv.abp9688 · Cited by 21 · see citing works
Self-citationOptimal Clinical Management and the Molecular Biology of Angiosarcomas
Chen, T. W., Burns, J., Jones, R. L., & Huang, P. H. (2020) · Cancers · doi:10.3390/cancers12113321 · Cited by 21 · see citing works
Dynamics of allosteric regulation of the phospholipase C-γ isozymes upon recruitment to membranes
Siraliev-Perez, E., Stariha, J. T., Hoffmann, R. M., Temple, B. R., Zhang, Q., Hajicek, N., Jenkins, M. L., Burke, J. E., & Sondek, J. (2022) · eLife · doi:10.7554/elife.77809 · Cited by 18 · see citing works
Li, K., Ran, B., Wang, Y., Liu, L., & Li, W. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.999061 · Cited by 18 · see citing works
Bartelt, R. R., Light, J. J., Vacaflores, A., Butcher, A. K., Pandian, M., Nash, P., & Houtman, J. C. D. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2015.06.002 · Cited by 18 · see citing works
Walliser, C., Wist, M., Hermkes, E., Zhou, Y., Schade, A., Haas, J., Deinzer, J., Désiré, L., Li, S. S. C., Stilgenbauer, S., et al. (2018) · Oncotarget · doi:10.18632/oncotarget.26173 · Cited by 17 · see citing works
Cruz‐Orcutt, N., Vacaflores, A., Connolly, S. F., Bunnell, S. C., & Houtman, J. C. D. (2014) · Cellular Signalling · doi:10.1016/j.cellsig.2013.12.022 · Cited by 17 · see citing works
Cruz-Duarte, R., de Almeida, C. R., Negrão, M., Fernandes, A., Borralho, P., Sobral, D., Gallego-Paez, L. M., Machado, D., Gramaça, J., Vı́lchez, J. M., et al. (2022) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT) · Cited by 16 · see citing works
Self-citationFar beyond anti-angiogenesis: Benefits for anti-basicFGF therapy in cancer
Li, C., Kuang, K., Du, J., Eymin, B., & Jia, T. (2022) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2022.119253 · Cited by 15 · see citing works
Human PLCG2 haploinsufficiency results in a novel natural killer cell immunodeficiency
Alinger, J. B., Mace, E. M., Porter, J. R., Mah-Som, A. Y., Daugherty, A. L., Li, S., Throm, A. A., Pingel, J. T., Saucier, N., Yao, A., et al. (2023) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2023.09.002 · Cited by 12 · see citing works
Reduced PLCG1 expression is associated with inferior survival for myelodysplastic syndromes
Shiseki, M., Ishii, M., Miyazaki, M., Osanai, S., Wang, Y., Yoshinaga, K., Mori, N., & Tanaka, J. (2019) · Cancer Medicine · doi:10.1002/cam4.2717 · Cited by 12 · see citing works
Conformational switches that control the TEC kinase – PLCγ signaling axis
Lowe, J., Joseph, R. E., & Andreotti, A. H. (2022) · Journal of Structural Biology X · doi:10.1016/j.yjsbx.2022.100061 · Cited by 12 · see citing works
Dynamic Allostery in PLCγ1 and Its Modulation by a Cancer Mutation Revealed by MD Simulation and NMR
Koss, H., Bunney, T. D., Esposito, D., Martins, M., Katan, M., & Driscoll, P. C. (2018) · Biophysical Journal · doi:10.1016/j.bpj.2018.05.031 · Cited by 10 · see citing works
Self-citationKapturska, K., & Pawlak, A. (2023) · Veterinary and Comparative Oncology · doi:10.1111/vco.12917 · Cited by 9 · see citing works
Time-resolved FRET reports FGFR1 dimerization and formation of a complex with its effector PLCγ1
Perdios, L., Bunney, T. D., Warren, S. C., Dunsby, C. W., French, P. M. W., Tate, E. W., & Katan, M. (2015) · Advances in Biological Regulation · doi:10.1016/j.jbior.2015.09.002 · Cited by 9 · see citing works
Self-citationPerdios, L., Lowe, A. R., Saladino, G., Bunney, T. D., Thiyagarajan, N., Alexandrov, Y., Dunsby, C. W., French, P. M. W., Chin, J. W., Gervasio, F. L., et al. (2017) · Scientific Reports · doi:10.1038/srep39841 · Cited by 9 · see citing works
Self-citationReverse Binding Mode of Phosphotyrosine Peptides with SH2 Protein
Wang, R. Y., Leung, P. Y. M., Huang, F., Tang, Q., Kaneko, T., Huang, M. J., Li, Z., Li, S. S. ‐., Wang, Y., & Xia, J. (2018) · Biochemistry · doi:10.1021/acs.biochem.8b00677 · Cited by 9 · see citing works
The Conformational State of the BTK Substrate PLCγ Contributes to Ibrutinib Resistance
Joseph, R. E., Lowe, J., Fulton, D. B., Engen, J. R., Wales, T. E., & Andreotti, A. H. (2021) · Journal of Molecular Biology · doi:10.1016/j.jmb.2021.167422 · Cited by 6 · see citing works
Contemporary diagnostic approach to atypical vascular lesion and angiosarcoma
Rutland, C. D., Bean, G. R., & Charville, G. W. (2023) · Seminars in Diagnostic Pathology · doi:10.1053/j.semdp.2023.04.017 · Cited by 9 · see citing works
Grb-ing receptor activation by the tail
Fearon, A. E., & Grose, R. P. (2014) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.2767 · Cited by 8 · see citing works
Skelton, L. A., & Boron, W. F. (2015) · Physiological Reports · doi:10.14814/phy2.12280 · Cited by 8 · see citing works
SH2 Domain Structures and Interactions
Gopalasingam, P., Quill, L., Jeeves, M., & Overduin, M. (2015) · Springer eBooks · doi:10.1007/978-3-319-20098-9_8 · Cited by 7 · see citing works
Tripathi, N., Vetrivel, I., Télétchéa, S., Jean, M., Legembre, P., & Laurent, A. D. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20194721 · Cited by 7 · see citing works
Нейропластичность мозга: мозговой нейротрофический фактор и протеинкиназные сигнальные пути
Викторовна, М. Е., & Levchuk, L. A. (2022) · Сибирский вестник психиатрии и наркологии · doi:10.26617/1810-3111-2022-3(116)-44-53 · Cited by 6 · see citing works
Samarina, N., Ssebyatika, G. L., Tikla, T., Waldmann, J.-Y., Abere, B., Nanna, V., Marasco, M., Carlomagno, T., Krey, T., & Schulz, T. F. (2021) · PLoS Pathogens · doi:10.1371/journal.ppat.1009635 · Cited by 6 · see citing works
T Cell Receptor Pathway Mutations in Mature T Cell Lymphomas
Zhang, Y., Cheng, K., & Choi, J. (2023) · Journal of Immunology · doi:10.4049/jimmunol.2200682 · Cited by 4 · see citing works
Hamdi, M., Al-Matwi, M. A., Elghoul, N., Al-Kuwari, H., Sayed, T. S., Riguene, E., & Nomikos, M. (2025) · Medicina · doi:10.3390/medicina61061054 · Cited by 5 · see citing works
In unity, there is strength: Phase separation controls receptor tyrosine kinase signal transduction
Salinas, A. J., & Lee, Y. K. (2022) · Molecular Cell · doi:10.1016/j.molcel.2022.03.003 · Cited by 5 · see citing works
Exposed: The Many and Varied Roles of Phospholipase C γ SH2 Domains
Driscoll, P. C. (2015) · Journal of Molecular Biology · doi:10.1016/j.jmb.2015.06.002 · Cited by 4 · see citing works
Self-citationWang, Q., Tao, C., Wu, Y., Anderson, K. E., Makrides, N., Hannan, A., Peregrin, J., Lin, C., Ding, Z., Li, W., et al. (2025) · Cell Reports · doi:10.1016/j.celrep.2025.116046 · Cited by 3 · see citing works
Krainer, J., Hendling, M., Siebenhandl, S., Fuehner, S., Kessel, C., Verweyen, E. L., Vierlinger, K., Foell, D., Schönthaler, S., & Weinhäusel, A. (2023) · Biomolecules · doi:10.3390/biom13091392 · Cited by 3 · see citing works
Gierschik, P., Buehler, A., & Walliser, C. (2012) · Structure · doi:10.1016/j.str.2012.11.009 · Cited by 3 · see citing works
Everett, K. L., & Katan, M. (2016) · Encyclopedia of Cell Biology · doi:10.1016/b978-0-12-394447-4.30017-7 · Cited by 3 · see citing works
Self-citationCui, H., Duan, R., Niu, H., Yu, T., Huang, K., Chen, C., Hao, K., Yang, T., & Wang, C. (2022) · BMC Pulmonary Medicine · doi:10.1186/s12890-022-01945-9 · Cited by 2 · see citing works
Li, X. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-15793-6.00004-4 · Cited by 2 · see citing works
Phospholipase C Isoform Functions in Immune Cells
Vines, C. M. (2014) · Springer eBooks · doi:10.1007/978-1-4939-0464-8_13
Conley, J. M. (2019) · eScholarship@UMassChan · doi:10.13028/mjvg-ne97
Molecular insight into the autoinhibition of a master regulator of lipid signalling in human disease
Burke, J. E. (2020) · EBioMedicine · doi:10.1016/j.ebiom.2020.102634
Physiological Roles of Phospholipase Cγ and Its Mutations in Human Disease
Jang, H., Choi, J. H., & Chang, J. (2020) · Scholarworks@UNIST (Ulsan National Institute of Science and Technology) · doi:10.5352/jls.2020.30.9.826
Milner, J. D. (2020) · Springer eBooks · doi:10.1007/978-1-4614-9209-2_126-1
Milner, J. D. (2020) · Springer eBooks · doi:10.1007/978-1-4614-8678-7_126
Everett, K. L., & Katan, M. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-821618-7.30017-7
Self-citationCruz-Duarte, R., de Almeida, C. R., Negrão, M., Fernandes, A., Borralho, P., Sobral, D., Gallego-Paez, L. M., Machado, D., Gramaça, J., Vı́lchez, J. M., et al. (2023) · doi:10.1158/1078-0432.c.6531303
Self-citationCruz-Duarte, R., de Almeida, C. R., Negrão, M., Fernandes, A., Borralho, P., Sobral, D., Gallego-Paez, L. M., Machado, D., Gramaça, J., Vı́lchez, J. M., et al. (2023) · doi:10.1158/1078-0432.c.6531303.v1
Self-citationWang, Q., Tao, C., Wu, Y., Anderson, K. E., Hannan, A., Lin, C., Hawkins, P. T., Stephens, L., & Zhang, X. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.06.28.601066
Bunney, T. D., Nyvall, H. G., Macrae, C., Lalović, D., Gregory, A., Huray, K. I. P. L., Harvey, N., Pinotsis, N., Kalli, A. C., Waudby, C. A., et al. (2025) · Biochemical Journal · doi:10.1042/bcj20253358
Self-citationAnálisis de redes complejas en sistemas biomoleculares
Berenstein, A. J. (2014) · Repositorio Digital Institucional de la Universidad de Buenos Aires (Universidad de Buenos Aires)
Cui, H., Duan, R., Niu, H., Yu, T., Huang, K., Chen, C., Hao, K., Yang, T., & Wang, C. (2022) · Figshare · doi:10.6084/m9.figshare.19695525
Cui, H., Wang, N., Min, F., Pei, H., Wang, Y., Li, H., Wan, Q., Meng, Y., He, M., Lv, X., et al. (2026) · Cellular & Molecular Biology Letters · doi:10.1186/s11658-026-00918-8
Saleh, A. I., Huang, Z., Islam, Z., Swann, K., & Nomikos, M. (2026) · Journal of Assisted Reproduction and Genetics · doi:10.1007/s10815-026-04023-9
- Authors
- Bunney, T. D., Esposito, D., Mas-Droux, C., Lamber, E., Baxendale, R. W., Martins, M., Cole, A., Svergun, D., Driscoll, P. C., & Katan, M.
- Affiliations
- Institute of Structural and Molecular Biology (GB)
- National Institute for Medical Research (GB)
- Research Institute of Molecular Pathology (AT)
- Birkbeck, University of London (GB)
- Deutsches Elektronen-Synchrotron DESY (DE)
- Corresponding author
- Katan, Matilda
- ORCID
- Venue
- Structure
- Publisher
- Elsevier BV
- Published
- 2012-12
- Volume
- 20
- Issue
- 12
- Pages
- 2062-2075
- ISSN
- 0969-2126 (ISSN-L)
- PMC
- PMC3532599
- OpenAlex
- W2061677225
- Cited by
- 88
- References
- 28
- Citations by year
- 2026: 2 · 2025: 3 · 2024: 2 · 2023: 7 · 2022: 12 · 2021: 7 · 2020: 12 · 2019: 7 · 2018: 4 · 2017: 4 · 2016: 5 · 2015: 10 · 2014: 11 · 2013: 1 · 2012: 1
- FWCI
- 2.96
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Structure (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- BIROn (Birkbeck, University of London) (submittedVersion)
- Funders
- Cancer Research UK
- National Institutes of Health
- Medical Research Council
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Tyrosine Phosphatases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Structure and Dynamics
- Keywords
- PLCγ1, interaction domains, SH2 domain, SH3 domain, autoinhibition, intramolecular interactions, fibroblast growth factor receptor signaling, protein phosphorylation, gain-of-function mutations, immune disorders, protein structure
- MeSH terms
- Animals, Cell Line, Enzyme Activation, Humans, Inositol Phosphates, Kinetics, Models, Molecular, Phosphorylation, Protein Binding, Protein Processing, Post-Translational, Thermodynamics, Signal Transduction, Mutagenesis, Site-Directed, Protein Structure, Secondary, Crystallography, X-Ray, Nuclear Magnetic Resonance, Biomolecular, Amino Acid Substitution, Catalytic Domain, Amino Acid Motifs, Sus scrofa, Receptor, Fibroblast Growth Factor, Type 1, Phospholipase C gamma, Protein Interaction Domains and Motifs
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review